Stephen P. Andrews

2.9k total citations
27 papers, 1.4k citations indexed

About

Stephen P. Andrews is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Stephen P. Andrews has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in Stephen P. Andrews's work include Receptor Mechanisms and Signaling (8 papers), Chemical Synthesis and Analysis (7 papers) and Neuropeptides and Animal Physiology (5 papers). Stephen P. Andrews is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Chemical Synthesis and Analysis (7 papers) and Neuropeptides and Animal Physiology (5 papers). Stephen P. Andrews collaborates with scholars based in United Kingdom, Switzerland and Norway. Stephen P. Andrews's co-authors include Fiona H. Marshall, Malcolm Weir, Miles Congreve, Jonathan S. Mason, Andrei Zhukov, A.S. Dore, Benjamin G. Tehan, James C. Errey, N.J. Robertson and Ali Jazayeri and has published in prestigious journals such as Nature, Chemical Reviews and Angewandte Chemie International Edition.

In The Last Decade

Stephen P. Andrews

26 papers receiving 1.3k citations

Peers

Countries citing papers authored by Stephen P. Andrews

Since Specialization

Citations

This map shows the geographic impact of Stephen P. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Andrews more than expected).

Fields of papers citing papers by Stephen P. Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen P. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Andrews. The network helps show where Stephen P. Andrews may publish in the future.

Co-authorship network of co-authors of Stephen P. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen P. Andrews. A scholar is included among the top collaborators of Stephen P. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen P. Andrews. Stephen P. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibiting Ca2+ channels in Alzheimer’s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia 2024 ·Nature Neuroscience ·Nils Korte, Anna Barkaway, Jack A. Wells, Felipe Freitas, Huma Sethi, Stephen P. Andrews, John Skidmore, Beth Stevens, David Attwell	18
2	The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) 2023 ·RSC Medicinal Chemistry ·(unknown), Timothy P. C. Rooney, Henriëtte M. G. Willems, (unknown), Christopher Green, (unknown), John Skidmore, Jonathan H. Clarke, Stephen P. Andrews	1
3	Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor 2023 ·RSC Medicinal Chemistry ·Henriëtte M. G. Willems, Simon Edwards, (unknown), (unknown), Christopher Green, (unknown), (unknown), John Skidmore, Jonathan H. Clarke, Stephen P. Andrews	5
4	Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode 2022 ·Journal of Medicinal Chemistry ·(unknown), Timothy P. C. Rooney, Henriëtte M. G. Willems, Simon Edwards, Christopher Green, Tina Howard, D. Ogg, (unknown), Duncan E. Scott, (unknown), James A. Duce, John Skidmore, Jonathan H. Clarke, Stephen P. Andrews	16
5	The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules 2022 ·Journal of Medicinal Chemistry ·Timothy P. C. Rooney, (unknown), (unknown), Henriëtte M. G. Willems, Simon Edwards, (unknown), Duncan E. Scott, Christopher Green, (unknown), John Skidmore, Jonathan H. Clarke, Stephen P. Andrews	11
6	Systematic Investigation of the Permeability of Androgen Receptor PROTACs 2020 ·ACS Medicinal Chemistry Letters ·Duncan E. Scott, Timothy P. C. Rooney, Elliott D. Bayle, (unknown), Henriëtte M. G. Willems, Jonathan H. Clarke, Stephen P. Andrews, John Skidmore	53
7	Crystal structure of the GLP-1 receptor bound to a peptide agonist 2017 ·Nature ·Ali Jazayeri, Mathieu Rappas, Alastair Brown, James Kean, James C. Errey, N.J. Robertson, Cédric Fiez-Vandal, Stephen P. Andrews, Miles Congreve, Andrea Bortolato, Jonathan Mason, Asma Baig, Iryna Teobald, A.S. Dore, Malcolm Weir, Roger Cooke, Fiona H. Marshall	136
8	Extra-helical binding site of a glucagon receptor antagonist 2016 ·Nature ·Ali Jazayeri, A.S. Dore, (unknown), Harini Krishnamurthy, Stacey M. Southall, Asma Baig, Andrea Bortolato, Markus Koglin, N.J. Robertson, James C. Errey, Stephen P. Andrews, Iryna Teobald, Alastair Brown, Roger Cooke, Malcolm Weir, Fiona H. Marshall	169
9	Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities 2015 ·Current Topics in Medicinal Chemistry ·Stephen P. Andrews, (unknown), J.A. Christopher, (unknown)	16
10	Structure‐Based and Fragment‐Based GPCR Drug Discovery 2013 ·ChemMedChem ·Stephen P. Andrews, Giles A. Brown, J.A. Christopher	56
11	Discovery of 1,2,4-Triazine Derivatives as Adenosine A_2A Antagonists using Structure Based Drug Design 2012 ·Journal of Medicinal Chemistry ·Miles Congreve, Stephen P. Andrews, A.S. Dore, Kaspar Hollenstein, Edward Hurrell, Christopher J. Langmead, Jonathan S. Mason, Irene W. Ng, Benjamin G. Tehan, Andrei Zhukov, Malcolm Weir, Fiona H. Marshall	264
12	Identification of Novel Adenosine A_2A Receptor Antagonists by Virtual Screening 2012 ·Journal of Medicinal Chemistry ·Christopher J. Langmead, Stephen P. Andrews, Miles Congreve, James C. Errey, Edward Hurrell, Fiona H. Marshall, Jonathan S. Mason, Christine M. Richardson, N.J. Robertson, Andrei Zhukov, Malcolm Weir	111
13	Stabilised G protein-coupled receptors in structure-based drug design: a case study with adenosine A_2A receptor 2012 ·MedChemComm ·Stephen P. Andrews, Benjamin G. Tehan	17
14	Biophysical Mapping of the Adenosine A_2A Receptor 2011 ·Journal of Medicinal Chemistry ·Andrei Zhukov, Stephen P. Andrews, James C. Errey, N.J. Robertson, Benjamin G. Tehan, Jonathan S. Mason, Fiona H. Marshall, Malcolm Weir, Miles Congreve	95
15	Enantioselective Preparation of 1,1‐Diarylethanes: Aldehydes as Removable Steering Groups for Asymmetric Synthesis 2007 ·Angewandte Chemie International Edition ·Thomas C. Fessard, Stephen P. Andrews, Hajime Motoyoshi, Erick M. Carreira	109
16	Design and total synthesis of unnatural analogues of the sub-nanomolar SERCA inhibitor thapsigargin 2007 ·Organic & Biomolecular Chemistry ·Stephen P. Andrews, (unknown), Matthew Ball, Steven V. Ley	17
17	Total Synthesis of Five Thapsigargins: Guaianolide Natural Products Exhibiting Sub‐Nanomolar SERCA Inhibition 2007 ·Chemistry - A European Journal ·Stephen P. Andrews, Matthew Ball, (unknown), Ed Cleator, Steven F. Oliver, Klemens Högenauer, Oliver Simić, Alessandra Antonello, (unknown), Martin D. Smith, Steven V. Ley	74
18	Enantioselektive Synthese von 1,1‐Diarylethanen: Aldehyde als entfernbare Steuerungsgruppen in der asymmetrischen Synthese 2007 ·Angewandte Chemie ·Thomas C. Fessard, Stephen P. Andrews, Hajime Motoyoshi, Erick M. Carreira	33
19	Copper- and Palladium-Containing Perovskites: Catalysts for the Ullmann and Sonogashira Reactions 2005 ·Synlett ·Steven V. Ley, Sophie Lohmann, Stephen P. Andrews, Brenda J. Burke, Martin D. Smith, J. Paul Attfield, Hirohisa Tanaka, Kimiyoshi Kaneko	13
20	Automated Parallel, Multi-Step Polymer-Assisted Solution Phase (PASP) Synthesis of Substituted Benzimidazole Derivatives 2004 ·Combinatorial Chemistry & High Throughput Screening ·Stephen P. Andrews, Daniel Jönsson, Brian H. Warrington, Mark Ladlow	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact